Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.
Köp den här e-boken och få 1 till GRATIS!
Språk Engelska ● Formatera PDF ● Sidor 84 ● ISBN 9780309159555 ● Redaktör Adam C. Berger & Steve Olson ● Utgivare National Academies Press ● Publicerad 2010 ● Nedladdningsbara 3 gånger ● Valuta EUR ● ID 7141707 ● Kopieringsskydd Adobe DRM
Kräver en DRM-kapabel e-läsare